North America Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity

North America pharmaceutical continuous manufacturing market is expected to grow by 9.5% annually in the forecast period and reach $851.9 million by 2030 driven by advantages offered by continuous manufacturing process such as cost saving and improved productivity.
Highlighted with 25 tables and 39 figures, this 106-page report “North America Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Country.

Based on Product, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Integrated Continuous Systems
Semi-Continuous Systems
• Continuous Granulators
• Continuous Blenders
• Continuous Compressors
• Continuous Coaters
• Continuous Dryers
• Other Semi-Continuous Systems
Controls & Software

Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
End Product Manufacturing
• Solid Dosage Manufacturing
• Liquid Dosage Manufacturing
API Manufacturing

Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Research Organizations and Institutes
• Other End Users

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrüder Lödige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 27
2.4 Emerging Opportunities and Market Trends 30
2.5 Porter’s Fiver Forces Analysis 34
3 Segmentation of North America Market by Product 40
3.1 Market Overview by Product 40
3.2 Integrated Continuous Systems 42
3.3 Semi-Continuous Systems 43
3.3.1 Continuous Granulators 45
3.3.2 Continuous Blenders 46
3.3.3 Continuous Compressors 47
3.3.4 Continuous Coaters 48
3.3.5 Continuous Dryers 49
3.3.6 Other Semi-Continuous Systems 50
3.4 Controls & Software 51
4 Segmentation of North America Market by Application 52
4.1 Market Overview by Application 52
4.2 End Product Manufacturing 54
4.2.1 Solid Dosage Manufacturing 56
4.2.2 Liquid Dosage Manufacturing 57
4.3 API Manufacturing 58
5 Segmentation of North America Market by End User 60
5.1 Market Overview by End User 60
5.2 Pharmaceutical Companies 62
5.3 Contract Manufacturing Organizations 63
5.4 Research Organizations and Institutes 64
5.5 Other End Users 65
6 North America Market 2019-2030 by Country 66
6.1 Overview of North America Market 66
6.2 U.S. 69
6.3 Canada 73
6.4 Mexico 75
7 Competitive Landscape 77
7.1 Overview of Key Vendors 77
7.2 New Product Launch, Partnership, Investment, and M&A 80
7.3 Company Profiles 81
ACG Group 81
Alexanderwerk 83
Baker Perkins Ltd. 84
Coperion GmbH 85
Fette Compacting 86
Freund-vector Corporation 87
GEA Group AG 88
Gebrüder Lödige Maschinenbau GmbH 89
Gericke AG 90
Glatt GmbH 91
Hosokawa Micron Corporation 92
Korsch AG 93
Leistritz AG 94
Munson Machinery Company, Inc. 95
Powrex Corp 96
Scott Equipment Company 97
Sturtevant, Inc. 98
Thermo Fisher Scientific Inc. 99
8 Investing in North America Market: Risk Assessment and Management 100
8.1 Risk Evaluation of North America Market 100
8.2 Critical Success Factors (CSFs) 103
Related Reports and Products 106

Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrüder Lödige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
Table 1. Snapshot of North America Pharmaceutical Continuous Manufacturing Market, 2019-2030 17
Table 2. Growth Rate of World Real GDP, 2017-2021 20
Table 3. Main Product Trends and Market Opportunities in North America Pharmaceutical Continuous Manufacturing Market 30
Table 4. North America Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 40
Table 5. North America Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems by Type, 2019-2030, $ mn 44
Table 6. North America Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 52
Table 7. North America Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing by Type, 2019-2030, $ mn 55
Table 8. North America Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 60
Table 9. North America Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn 67
Table 10. U.S. Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 71
Table 11. U.S. Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 71
Table 12. U.S. Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 71
Table 13. Canada Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 74
Table 14. Canada Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 74
Table 15. Canada Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 74
Table 16. Mexico Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 76
Table 17. Mexico Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 76
Table 18. Mexico Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 76
Table 19. ACG Group: Company Snapshot 81
Table 20. ACG Group: Business Segmentation 81
Table 21. ACG Group: Product Portfolio 82
Table 22. ACG Group: Revenue, 2016-2018, $ mn 82
Table 23. ACG Group: Recent Developments 82
Table 24. Risk Evaluation for Investing in North America Market, 2019-2030 101
Table 25. Critical Success Factors and Key Takeaways 104
Figure 1. Research Method Flow Chart 10
Figure 2. Breakdown of Primary Research 12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 5. North America Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn 18
Figure 6. Impact of COVID-19 on Business 22
Figure 7. Primary Drivers and Impact Factors of North America Pharmaceutical Continuous Manufacturing Market 24
Figure 8. Primary Restraints and Impact Factors of North America Pharmaceutical Continuous Manufacturing Market 27
Figure 9. Investment Opportunity Analysis 31
Figure 10. Porter’s Fiver Forces Analysis of North America Pharmaceutical Continuous Manufacturing Market 34
Figure 11. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, % of Sales Revenue 40
Figure 12. North America Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 41
Figure 13. North America Pharmaceutical Continuous Manufacturing Market: Integrated Continuous Systems, 2019-2030, $ mn 42
Figure 14. North America Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems, 2019-2030, $ mn 43
Figure 15. North America Pharmaceutical Continuous Manufacturing Market: Continuous Granulators, 2019-2030, $ mn 45
Figure 16. North America Pharmaceutical Continuous Manufacturing Market: Continuous Blenders, 2019-2030, $ mn 46
Figure 17. North America Pharmaceutical Continuous Manufacturing Market: Continuous Compressors, 2019-2030, $ mn 47
Figure 18. North America Pharmaceutical Continuous Manufacturing Market: Continuous Coaters, 2019-2030, $ mn 48
Figure 19. North America Pharmaceutical Continuous Manufacturing Market: Continuous Dryers, 2019-2030, $ mn 49
Figure 20. North America Pharmaceutical Continuous Manufacturing Market: Other Semi-Continuous Systems, 2019-2030, $ mn 50
Figure 21. North America Pharmaceutical Continuous Manufacturing Market: Controls & Software, 2019-2030, $ mn 51
Figure 22. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, % of Sales Revenue 53
Figure 23. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 53
Figure 24. North America Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing, 2019-2030, $ mn 54
Figure 25. North America Pharmaceutical Continuous Manufacturing Market: Solid Dosage Manufacturing, 2019-2030, $ mn 56
Figure 26. North America Pharmaceutical Continuous Manufacturing Market: Liquid Dosage Manufacturing, 2019-2030, $ mn 57
Figure 27. North America Pharmaceutical Continuous Manufacturing Market: API Manufacturing, 2019-2030, $ mn 58
Figure 28. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, % of Revenue 61
Figure 29. North America Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 61
Figure 30. North America Pharmaceutical Continuous Manufacturing Market: Pharmaceutical Companies, 2019-2030, $ mn 62
Figure 31. North America Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations, 2019-2030, $ mn 63
Figure 32. North America Pharmaceutical Continuous Manufacturing Market: Research Organizations and Institutes, 2019-2030, $ mn 64
Figure 33. North America Pharmaceutical Continuous Manufacturing Market: Other End Users, 2019-2030, $ mn 65
Figure 34. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue 67
Figure 35. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 68
Figure 36. U.S. Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn 70
Figure 37. Canada Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn 73
Figure 38. Pharmaceutical Continuous Manufacturing Market in Mexico, 2015-2030, $ mn 75
Figure 39. Growth Stage of North America Pharmaceutical Continuous Manufacturing Industry over the Forecast Period 77

Frequently Asked Questions About This Report

Choose License Type

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

Our Clients

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.